KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onto Innovation (ONTO) Asset Writedowns and Impairment: 2010-2019

Historic Asset Writedowns and Impairment for Onto Innovation (ONTO) over the last 10 years, with Q3 2019 value amounting to $1.2 million.

  • Onto Innovation's Asset Writedowns and Impairment rose 10249.58% to $1.2 million in Q3 2019 from the same period last year, while for Sep 2019 it was $5.9 million, marking a year-over-year increase of 50994.82%. This contributed to the annual value of $3.0 million for FY2018, which is 4910.89% up from last year.
  • As of Q3 2019, Onto Innovation's Asset Writedowns and Impairment stood at $1.2 million, which was up 10249.58% from $1.2 million recorded in Q2 2019.
  • In the past 5 years, Onto Innovation's Asset Writedowns and Impairment registered a high of $2.1 million during Q4 2018, and its lowest value of $95000.0 during Q1 2018.
  • In the last 5 years, Onto Innovation's Asset Writedowns and Impairment had a median value of $609000.0 in 2017 and averaged $732947.4.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first tumbled by 7660.1% in 2018, then skyrocketed by 173894.74% in 2019.
  • Over the past 5 years, Onto Innovation's Asset Writedowns and Impairment (Quarter) stood at $674000.0 in 2015, then fell by 2.23% to $659000.0 in 2016, then decreased by 7.74% to $608000.0 in 2017, then skyrocketed by 252.3% to $2.1 million in 2018, then tumbled by 43.18% to $1.2 million in 2019.
  • Its Asset Writedowns and Impairment was $1.2 million in Q3 2019, compared to $1.2 million in Q2 2019 and $1.7 million in Q1 2019.